Last updated: February 21, 2026
NDC 51407-0765 refers to a specific pharmaceutical product. While the exact drug name is not specified, this label typically indicates a branded or generic drug registered with the U.S. Food and Drug Administration (FDA). The analysis below uses available industry data, historical pricing trends, and market dynamics relevant to similar drug profiles to generate detailed insights.
Drug Profile and Market Context
Product specifics:
- NDC: 51407-0765
- Manufacturer: [Data not provided; can vary]
- Formulation: [Likely to be injectable, oral, or topical based on NDC pattern]
- Indications: [Assumed to target a common chronic or acute condition]
- Patent Status: May be patent-protected or generic-divested depending on approval date
Market Landscape:
- Competitors: Several branded and generic alternatives
- Market Size: Estimated based on disease prevalence, pipeline activity, and existing drug consumption patterns
- Distribution Channels: Hospital formularies, retail pharmacies, specialty clinics
Pricing Trends
| Historical Price Data: |
Year |
Average Wholesale Price (AWP) |
Consumer Price |
Medicare Payment Rate |
| 2018 |
$___ |
$___ |
$___ |
| 2019 |
$___ |
$___ |
$___ |
| 2020 |
$___ |
$___ |
$___ |
| 2021 |
$___ |
$___ |
$___ |
| 2022 |
$___ |
$___ |
$___ |
Note: Specific prices fluctuate based on manufacturer discounts, payer negotiations, and formularies.
Price Drivers:
- Patent Status: Branded drugs often command premium prices; generic access reduces costs.
- Market Competition: Entry of generics can reduce prices up to 60% within two years.
- Distribution Costs: Factors such as supply chain efficiency influence retail and wholesale prices.
- Reimbursement Policies: CMS and private payers influence pricing through formulary decisions.
Market Forecast and Price Projections
Short-term (Next 12 Months):
- Pricing stability expected if patent exclusivity persists.
- Probable price decline post-generic entry, estimated at 30-50%.
- Average wholesale prices expected to adjust from current levels by 10-20% annually, influenced by market penetration.
Medium-term (1-3 Years):
- Prices may decline further if biosimilar or alternative therapies gain adoption.
- Price reductions may slow as market saturation occurs, with stabilization expected after the initial decline.
- Innovative formulations or authorized generics could temporarily sustain higher prices.
Long-term (3+ Years):
- Market saturation and competition likely to reduce prices by 50% or more from peak levels.
- Price recovery unlikely unless new indications or delivery systems are approved.
Key Regulatory and Market Factors
| Factor |
Impact on Price |
Description |
| Patent Expiry |
Drives prices down |
Availability of generics leads to competitive pricing. |
| FDA Approvals |
Can initiate price adjustments |
New indications or formulations influence market size and positioning. |
| Reimbursement Policies |
Affects price ceiling |
Payer restrictions influence drug affordability and sales volume. |
| Pipeline Developments |
Alters market share |
Potential new entrants or biosimilars threaten existing pricing structures. |
Competitive Landscape
| Drug Name |
Manufacturer |
Indication |
Formulation |
Price Range (USD) |
Market Share (Estimate) |
| Drug A |
XYZ Pharma |
Condition X |
Injectable |
$ - $ |
45% |
| Drug B |
ABC Inc. |
Condition X |
Oral |
$ - $ |
25% |
| Generic C |
Various |
Condition X |
Various |
$ - $ |
15% |
| Others |
-- |
-- |
-- |
$ - $ |
15% |
Note: Exact market shares vary by region and payer mix.
Strategic Recommendations
- Monitor patent status and regulatory filings for biosimilar or generic entrants.
- Engage with payers to understand formulary placement and reimbursement trends.
- Evaluate pipeline developments and pipeline fit for potential market shifts.
- Consider cost-plus or value-based pricing models aligned with market positioning.
Key Takeaways
- Immediate pricing impact depends on patent status and market exclusivity.
- Generic competition expected to reduce prices by 30-50% within 1-2 years.
- Long-term prices likely to stabilize at significantly lower levels after generic entry.
- Market size and share are influenced heavily by competitive dynamics and regulatory approvals.
FAQs
Q1: What factors influence the pricing of NDC 51407-0765 in the short term?
Patent status, manufacturing costs, payer negotiations, and existing competition influence selling prices.
Q2: How quickly do prices typically decline after generic entry?
Prices can decrease by 30-50% within the first two years post-generic approval.
Q3: What is the impact of biosimilar entries on this drug’s market?
Biosimilars can further reduce prices and increase market share competition.
Q4: Are there regulatory pathways that could sustain higher prices?
Yes. Approvals for new indications, formulations, or delivery methods can sustain higher prices temporarily.
Q5: How do payer policies influence the drug’s market penetration?
Formulary restrictions, reimbursement limits, and negotiated discounts impact sales and pricing strategies.
Sources
[1] Food and Drug Administration. (2023). NDC Directory.
[2] IQVIA. (2022). Market Trends and Pricing Data.
[3] Centers for Medicare & Medicaid Services. (2023). Drug Payment Policies.
[4] Medicare Part B and Part D formularies, 2023.
[5] EvaluatePharma. (2022). Forecasting Oncology & Specialty Drugs Market.
